Obesity treatment access in the United States: a state-level scorecard.

IF 3.8
John David Scott, Allyson Lynn Hale, Tracy Zvenyach, Joseph Nadglowski, Lisa Renee Hilton
{"title":"Obesity treatment access in the United States: a state-level scorecard.","authors":"John David Scott, Allyson Lynn Hale, Tracy Zvenyach, Joseph Nadglowski, Lisa Renee Hilton","doi":"10.1016/j.soard.2026.09.020","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Obesity affects more than 40% of U.S. adults and carries substantial morbidity and mortality, yet access to evidence-based treatment varies widely across jurisdictions.</p><p><strong>Objectives: </strong>To evaluate and compare state-level access to evidence-based obesity treatment across the United States using a standardized composite framework.</p><p><strong>Setting: </strong>50 U.S. states and the District of Columbia (51 jurisdictions).</p><p><strong>Methods: </strong>Ecological cross-sectional study using publicly available policy and administrative data aggregated in 2026; the unit of analysis was the jurisdiction and no individual patient-level data were used. The Obesity Treatment Access Scorecard was derived from 44 metrics across 6 weighted tiers, coverage, access barriers, workforce capacity, regulatory factors, patient context, and treatment utilization, yielding scores of 0-100 mapped to letter grades (A-F). Data were verified by expert review with multisource validation, and sensitivity analyses tested alternative tier-weighting schemes.</p><p><strong>Results: </strong>Scores ranged from 25.5 to 77.7 (mean, 48.5; standard deviation [SD], 12.8). No state achieved an A grade (≥80). Fifteen jurisdictions (29.4%) scored below 40 and 10 (19.6%) scored 60 or higher. Massachusetts (77.7) and Minnesota (76.4) ranked the highest; Arkansas (25.5), Oklahoma (28.5), and West Virginia (28.9) ranked the lowest. Mean scores were highest in the Northeast (62.7 [SD, 10.2]) and lowest in the South (39.9 [SD, 10.5]). Variability was greatest in the patient context and workforce capacity tiers. Jurisdiction rankings were robust to alternative tier-weighting schemes (Spearman ρ ≥ .99).</p><p><strong>Conclusions: </strong>Access to evidence-based obesity treatment is highly variable across the United States, with no state achieving top performance. These findings highlight significant geographic disparities and support the need for policy and system-level reforms. The Obesity Treatment Access Scorecard is presented as an exploratory benchmarking framework requiring further validation before use in policy evaluation.</p>","PeriodicalId":94216,"journal":{"name":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.soard.2026.09.020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Obesity affects more than 40% of U.S. adults and carries substantial morbidity and mortality, yet access to evidence-based treatment varies widely across jurisdictions.

Objectives: To evaluate and compare state-level access to evidence-based obesity treatment across the United States using a standardized composite framework.

Setting: 50 U.S. states and the District of Columbia (51 jurisdictions).

Methods: Ecological cross-sectional study using publicly available policy and administrative data aggregated in 2026; the unit of analysis was the jurisdiction and no individual patient-level data were used. The Obesity Treatment Access Scorecard was derived from 44 metrics across 6 weighted tiers, coverage, access barriers, workforce capacity, regulatory factors, patient context, and treatment utilization, yielding scores of 0-100 mapped to letter grades (A-F). Data were verified by expert review with multisource validation, and sensitivity analyses tested alternative tier-weighting schemes.

Results: Scores ranged from 25.5 to 77.7 (mean, 48.5; standard deviation [SD], 12.8). No state achieved an A grade (≥80). Fifteen jurisdictions (29.4%) scored below 40 and 10 (19.6%) scored 60 or higher. Massachusetts (77.7) and Minnesota (76.4) ranked the highest; Arkansas (25.5), Oklahoma (28.5), and West Virginia (28.9) ranked the lowest. Mean scores were highest in the Northeast (62.7 [SD, 10.2]) and lowest in the South (39.9 [SD, 10.5]). Variability was greatest in the patient context and workforce capacity tiers. Jurisdiction rankings were robust to alternative tier-weighting schemes (Spearman ρ ≥ .99).

Conclusions: Access to evidence-based obesity treatment is highly variable across the United States, with no state achieving top performance. These findings highlight significant geographic disparities and support the need for policy and system-level reforms. The Obesity Treatment Access Scorecard is presented as an exploratory benchmarking framework requiring further validation before use in policy evaluation.

美国肥胖症治疗的可及性:一个州级计分卡。
背景:肥胖影响着超过40%的美国成年人,并且具有很高的发病率和死亡率,然而在不同的司法管辖区,获得循证治疗的机会差异很大。目的:使用标准化的复合框架评估和比较美国各州对循证肥胖治疗的可及性。环境:美国50个州和哥伦比亚特区(51个司法管辖区)。方法:利用2026年收集的公开政策和行政数据进行生态横断面研究;分析单位为司法管辖区,没有使用个体患者水平的数据。肥胖治疗可及性记分卡由6个权重层的44个指标衍生而来,覆盖范围、可及性障碍、劳动力能力、监管因素、患者情况和治疗利用率,得到0-100分的字母等级(A-F)。数据通过多源验证的专家评审进行验证,敏感性分析测试了可选的分层加权方案。结果:评分范围为25.5 ~ 77.7(平均48.5;标准差[SD] 12.8)。没有州达到A级(≥80)。15个司法管辖区(29.4%)得分低于40分,10个(19.6%)得分在60分或以上。马萨诸塞州(77.7分)和明尼苏达州(76.4分)排名最高;阿肯色州(25.5分)、俄克拉荷马州(28.5分)和西弗吉尼亚州(28.9分)排名最低。平均得分最高的是东北部(62.7 [SD, 10.2]),最低的是南部(39.9 [SD, 10.5])。在患者环境和劳动力能力层中,可变性最大。司法管辖区排名对不同的层级加权方案具有稳健性(Spearman ρ≥0.99)。结论:在美国,获得循证肥胖治疗的机会差异很大,没有一个州达到最高水平。这些调查结果突出了显著的地域差异,支持了政策和制度层面改革的必要性。肥胖治疗可及性记分卡是作为一个探索性基准框架提出的,在用于政策评估之前需要进一步验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书